RecruitingNot Applicable

Validation of a Rapid Screening Tool for Anxiety-depressive Disorders in Children, Adolescents and Young Adults Treated in Oncology. Multicenter Study.

France545 participantsStarted 2025-03-18

Plain-language summary

In France today, it is estimated that one in every 850 people aged between 20 and 45 is a childhood cancer survivor (CCS), equivalent to around 40,000 to 50,000 people. Some descriptive studies have established that the diagnosis and treatment of cancer can affect psychological health. A French study published by our team in 2015 and 2020 showed that in adulthood, 40% of CCS had anxiety symptoms, a rate significantly higher than that of the general French population (25%). However, although there are validated scales for screening children for psychological disorders (anxiety, depression, etc.), there is no rapid screening tool that can be used routinely by an oncologist during consultations. So, the study aims to develop and validate a short test, which could easily be carried out systematically during follow-up consultations after childhood cancer. It would make it possible to identify people with no psychological complications and, conversely, those in whom further investigation, based on the classic reference scales for assessing psychological disorders, would be relevant.

Who can participate

Age range

7 Years – 25 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria * Patients diagnosed with pediatric cancer before the age of 18, * Patient whose intensive treatment had ended at least 3 months prior to inclusion, * Patients considered to be in complete remission by the doctor responsible for their treatment, * Patient affiliated to or entitled under a social security scheme, * Patient having received informed information about the study OR the holder(s) of parental authority having received informed information about the study in the case of minors. Exclusion Criteria * Refusal to participate expressed by the patient or minor, * Patients whose cancer has relapsed or progressed, * Pregnant women, women in labor, breast-feeding mothers, * Persons deprived of their liberty, hospitalized without consent, hospitalized for purposes other than those of the research, * Adults under legal protection (guardianship) or unable to express their consent.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

New rapid screening tool for anxiety-depressive disorders

Timeframe: At inclusion

SCARED-R-51 (Screen for Child Anxiety Related Emotional Disorders-Revised)

Timeframe: At inclusion

HADS (Hospital Anxiety and Depression Scale)

Timeframe: At inclusion

Trial details

NCT IDNCT07117058

SponsorCentre Hospitalier Universitaire de Saint Etienne

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-09

Contact for this trial

CLAIRE BERGER, MD

(0)4.77.12.79.37 claire.berger@chu-st-etienne.fr

View on ClinicalTrials.gov More Generalized Anxiety trials

Plain-language summary

Who can participate

Age range

7 Years – 25 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.